BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15729687)

  • 1. Ligand-activated Flpe for temporally regulated gene modifications.
    Hunter NL; Awatramani RB; Farley FW; Dymecki SM
    Genesis; 2005 Mar; 41(3):99-109. PubMed ID: 15729687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inducible gene inactivation in neurons of the adult mouse forebrain.
    Erdmann G; Schütz G; Berger S
    BMC Neurosci; 2007 Aug; 8():63. PubMed ID: 17683525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse.
    Hayashi S; McMahon AP
    Dev Biol; 2002 Apr; 244(2):305-18. PubMed ID: 11944939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2.
    Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F
    Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell type-specific conditional regulation of the c-myc proto-oncogene by combining Cre/loxP recombination and tamoxifen-mediated activation.
    Jäger R; Maurer J; Jacob A; Schorle H
    Genesis; 2004 Mar; 38(3):145-50. PubMed ID: 15048812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-contamination with tamoxifen induces transgene expression in non-exposed inducible transgenic mice.
    Brake RL; Simmons PJ; Begley CG
    Genet Mol Res; 2004 Dec; 3(4):456-62. PubMed ID: 15688312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A tamoxifen-inducible chimeric Cre recombinase specifically effective in the fetal and adult mouse liver.
    Tannour-Louet M; Porteu A; Vaulont S; Kahn A; Vasseur-Cognet M
    Hepatology; 2002 May; 35(5):1072-81. PubMed ID: 11981757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of Cre recombinase toxicity in proliferating Drosophila cells by estrogen-dependent activity regulation.
    Heidmann D; Lehner CF
    Dev Genes Evol; 2001 Sep; 211(8-9):458-65. PubMed ID: 11685583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducible site-specific recombination in the brain.
    Kellendonk C; Tronche F; Casanova E; Anlag K; Opherk C; Schütz G
    J Mol Biol; 1999 Jan; 285(1):175-82. PubMed ID: 9878397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducible transgenic mouse models.
    Saunders TL
    Methods Mol Biol; 2011; 693():103-15. PubMed ID: 21080277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A practical summary of site-specific recombination, conditional mutagenesis, and tamoxifen induction of CreERT2.
    Anastassiadis K; Glaser S; Kranz A; Berhardt K; Stewart AF
    Methods Enzymol; 2010; 477():109-23. PubMed ID: 20699139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using Flp-recombinase to characterize expansion of Wnt1-expressing neural progenitors in the mouse.
    Dymecki SM; Tomasiewicz H
    Dev Biol; 1998 Sep; 201(1):57-65. PubMed ID: 9733573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity of ligand-dependent Cre recombinases and generation of a conditional Cre deleter mouse allowing mosaic recombination in peripheral tissues.
    Hameyer D; Loonstra A; Eshkind L; Schmitt S; Antunes C; Groen A; Bindels E; Jonkers J; Krimpenfort P; Meuwissen R; Rijswijk L; Bex A; Berns A; Bockamp E
    Physiol Genomics; 2007 Sep; 31(1):32-41. PubMed ID: 17456738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FLP recombinase/estrogen receptor fusion proteins require the receptor D domain for responsiveness to antagonists, but not agonists.
    Nichols M; Rientjes JM; Logie C; Stewart AF
    Mol Endocrinol; 1997 Jun; 11(7):950-61. PubMed ID: 9178754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein.
    Sohal DS; Nghiem M; Crackower MA; Witt SA; Kimball TR; Tymitz KM; Penninger JM; Molkentin JD
    Circ Res; 2001 Jul; 89(1):20-5. PubMed ID: 11440973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conditional somatic mutagenesis in the mouse using site-specific recombinases.
    Feil R
    Handb Exp Pharmacol; 2007; (178):3-28. PubMed ID: 17203649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand-activated site-specific recombination in mice.
    Feil R; Brocard J; Mascrez B; LeMeur M; Metzger D; Chambon P
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10887-90. PubMed ID: 8855277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic mice expressing tamoxifen-inducible Cre for somatic gene modification in renal epithelial cells.
    Lantinga-van Leeuwen IS; Leonhard WN; van de Wal A; Breuning MH; Verbeek S; de Heer E; Peters DJ
    Genesis; 2006 May; 44(5):225-32. PubMed ID: 16652363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inducible Cx40-Cre expression in the cardiac conduction system and arterial endothelial cells.
    Beyer S; Kelly RG; Miquerol L
    Genesis; 2011 Feb; 49(2):83-91. PubMed ID: 21344610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of tamoxifen-regulated Cre activity in mice using a cartilage-specific CreER(T) to assay temporal activity windows along the proximodistal limb skeleton.
    Nakamura E; Nguyen MT; Mackem S
    Dev Dyn; 2006 Sep; 235(9):2603-12. PubMed ID: 16894608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.